Medical Resources meets with NASDAQ

Article

Imaging services provider Medical Resources of Hackensack, NJ, got at least a temporary reprieve from NASDAQ for its listing on the stock exchange, the company reported June 2. Medical Resources' NASDAQ listing was in jeopardy due to the company's

Imaging services provider Medical Resources of Hackensack, NJ, got at least a temporary reprieve from NASDAQ for its listing on the stock exchange, the company reported June 2. Medical Resources' NASDAQ listing was in jeopardy due to the company's inability to file its 10-K report with the Securities and Exchange Commission for 1997 financial results. The firm recently filed the report and will be able to maintain its listing, at least for the next several weeks.

NASDAQ set several conditions for the company's continued listing on the exchange. Medical Resources must file its quarterly 10-Q report for its first financial quarter (end-March) by June 12, and by July 24 must meet either NASDAQ's minimum net tangible assets requirement or an alternative requirement that its stock trade at a minimum bid of $5 a share. Medical Resources currently meets neither the tangible assets requirement nor the $5 a share requirement, although the company said it would implement a reverse stock split to meet the latter, if necessary.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.